Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II, Single Arm, Open Label Clinical Trial With Irinotecan in Combination With Cisplatin in Pediatric Patients With Unfavorable Prognosis Gliomas

NCT01574092 is registered in ClinicalTrials.gov with Hospital Sant Joan de Deu as lead sponsor.

NCT NCT01574092
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01574092 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II, Single Arm, Open Label Clinical Trial With Irinotecan in Combination With Cisplatin in Pediatric Patients With Unfavorable Prognosis Gliomas
Lead sponsor
Hospital Sant Joan de Deu
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2009
Completion date
March 31, 2015
Enrollment
39 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pediatric high risk gliomas